Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pea protein power: can a vegetarian diet change how your body uses plant protein?

NCT ID NCT07521189

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well people digest and use protein from peas, comparing young and older adults who are either vegetarians or omnivores. Researchers will measure protein absorption after a pea-based meal using special tracers. The goal is to understand if age or diet affects how the body handles plant protein, which could help improve nutrition for older adults.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pea protein
What this could lead to
If successful, this study could help design better nutritional strategies for older adults who need more protein, especially those on plant-based diets.
What could go wrong
This is an early-stage observational study with only 48 participants, so results may not apply to everyone. It measures digestion markers, not health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Normal weight or overweight (18 \< BMI \< 30 kg·m-²) * Male or female * Aged 18-23 years (young groups) or 65-75 years (older groups) * Following an omnivorous diet (regular consumption of meat products, with meat intake \> 3 times/week and \> 70% of protein intake from animal sources) or vegetarian diet (exclusion of meat and fish/seafood, with \> 70% of protein intake from plant sources) * In good general health (WHO = 0) * Affiliated with a social security system * Free and informed consent, provided in writing after receiving the information required by the Public Health Code Exclusion Criteria: * Adults under legal protection or unable to give informed consent (e.g., under guardianship, trusteeship, or legal protection) * Any known food allergy * Positive serology for HBsAg, anti-HBc, HCV, or HIV * Anemia: hemoglobin level \< 13 g/dL in men and \< 12 g/dL in women * Pregnant women or those who may be pregnant (based on a positive urine pregnancy test at inclusion) * Excessive alcohol consumption (\> 2 drinks/day). Harmful alcohol use will be assessed by the investigator at inclusion. * Hypertension, diabetes, gastrointestinal, liver or kidney diseases, or severe heart disease. These conditions will be assessed by the investigator based on standard clinical evaluation and participants' self-reports at inclusion. * Hypertension: significant arterial hypertension according to the investigator, or systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg at inclusion. * Diabetes: type 1 or type 2 diabetes, or fasting blood glucose \> 1.25 g/L. * Gastrointestinal disease: clinically significant gastrointestinal disorders (bleeding, vomiting, constipation/diarrhea grade \> 1) as judged by the investigator, any inflammatory bowel disease, or acute gastroenteritis in the month prior to the intervention. * Liver disease: any significant hepatic disorder according to the investigator, or ASAT/ALAT \> 2.5 times the upper normal limit. * High-level athletes (\> 8 hours of training per week) * Blood donation within 8 weeks prior to study start * Absence of free, informed, written consent after receiving the information required by the Public Health Code * Not affiliated with a social security system

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elderly are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre de Recherche sur Volontaire, Hopital Avicenne (AP-HP)

    RECRUITING

    Bobigny, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.